The pathological role of GDNF in AD is not completely understood; however, several studies have shown that depletion of this neurotrophic factor appears to be associated with symptoms and pathologies of AD, and could be a potential therapeutic option for neurodegeneration (Table 1). This evidence concerns the gene GDNF and Alzheimer disease.